Skip to main content
OpenTrials

Clinical trial condition

Diabetes

Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.

2,489 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Diabetes trial results

Completed

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

NCT02582242

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
Locations
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Oran, Algeria
  • Novo Nordisk Investigational Site Hefei, Anhui, China
View all 50 locations
View Trial Details
Completed

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

NCT01835431

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 73 locations
View Trial Details
Completed

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

NCT02670915

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Long Beach, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
View all 155 locations
View Trial Details
Completed

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

NCT02597127

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +19 more
Locations
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Midwest Institute For Clinical Research Indianapolis, Indiana, United States
  • Mount Sinai Icahn School of Medicine New York, United States
  • Metabolic And Atherosclerosis Research Center Cincinnati, Ohio, United States
View all 54 locations
View Trial Details

Related conditions